Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
AMRX: Amneal Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
AMRX
The Story
AMRX
Loading chart data...
Current State
Balance holding
The verdict
Good business
Mixed
Operating margin
7.9%
ROIC
8.2%
Financially safe
Adequate
Debt / equity
84.54×
Interest coverage
2.1×
Current ratio
2.20×
Valuation
Unrated
P/E ratio
37.6×
Amneal Pharmaceuticals, Inc.
AMRX
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Amneal Pharmaceuticals, Inc.
AMRX
NASDAQ
·
USD
·
Closed
$18.32
−0.97%
$18.32
−$0.18 (0.97%)
52W Range
92th
pctl
Volume
0.98×
avg
Mkt Cap
5.85B
USD
P/E
37.6
TTM
Div Yield
–
ann
52W Range
92th
pctl
Volume
0.98×
avg
Market Cap
5.85B
USD
P/E Ratio
37.6
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings